China Investment & Development (Cidc)

Eli Lilly CEO announces $27B manufacturing investment, hopes medicines will be exempt from tariffs

President Trump reiterates anger that U.S. pays more for drugs than other countries, says tariffs will spur domestic drug manufacturing

Led by Orbimed, LAV, Boyu, biotech’s Asia ‘NewCo Model’ goes global

Biotech VC Uciane Scarlett on getting the right mix of platform-to-asset

Lesson one from the Biosecure Act: U.S. biotech policy must focus on bolstering the domestic bioeconomy

Wuxi Apptec moves to preserve its core interests, GLP-1R deals showcase breadth of China biotech’s dealmaking

Pediatric priority review vouchers end at midnight tonight as House passes latest version of spending bill

In BioCentury’s Venture Report: Fundings for Citryll, Angitia, Tasca, Veradermics and more

Defense bill places biotech under national security umbrella

Rhodium Group report suggests Congress focus on economic rather than military threats from China biotech